[Studies and Real-World Experience Regarding the Clinical Application of Artificial Intelligence Software for Lung...

This article discusses studies and real-world experiences related to the clinical application of artificial intelligence-based computer-aided detection (AI-CAD) software (LuCAS-plus, Monitor Corporation) in detecting pulmonary nodules. During clinical trials for lung cancer screening, AI-CAD exhibited performance comparable to that of medical professionals in terms of sensitivity and specificity. Studies revealed that applying AI-CAD for diagnosing pulmonary metastases led to high detection rates. The use of a nodule matching algorithm in diagnosing pulmonary metastases significantly reduced false non-metastasis results. In clinical settings, implementing AI-CAD enhanced the efficiency of pulmonary nodule detection, saving time and effort during CT reading. Overall, AI-CAD is expected to offer substantial support for lung cancer screening and the interpretation of chest CT scans for malignant tumor surveillance.